Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake

Biomaterials

Volumn 75, Issue , 2016, Pages 295-304

  Mirshafiee, Vahid ^a   Kim, Raehyun ^a   Park, Soyun ^a,e   Mahmoudi, Morteza ^b,c   Kraft, Mary L ^a,d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fc receptor; Immunoglobulins; Nanoparticle; Opsonins; Protein corona; Targeted delivery

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BINS; CELL MEMBRANES; CELLS; COATINGS; CYTOLOGY; LIGANDS; MACROPHAGES; NANOPARTICLES;

FC-RECEPTORS; IMMUNOGLOBULINS; OPSONINS; PROTEIN CORONAS; TARGETED DELIVERY;

PROTEINS;

IMMUNOGLOBULIN; NANOCARRIER; OPSONIN; SILICA NANOPARTICLE; FC RECEPTOR; NANOPARTICLE; PROTEIN CORONA; SERUM ALBUMIN;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; MACROPHAGE; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CORONA; PROTEIN STRUCTURE; TARGET CELL; ANIMAL; CHEMISTRY; CONFOCAL MICROSCOPY; ENDOCYTOSIS; FLOW CYTOMETRY; HYDRODYNAMICS; LIQUID CHROMATOGRAPHY; METABOLISM; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAW 264.7 CELL LINE; STATIC ELECTRICITY; TANDEM MASS SPECTROMETRY; ULTRASTRUCTURE;

ANIMALS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOCYTOSIS; FLOW CYTOMETRY; GAMMA-GLOBULINS; HUMANS; HYDRODYNAMICS; MICE; MICROSCOPY, CONFOCAL; NANOPARTICLES; PARTICLE SIZE; PROTEIN CORONA; RAW 264.7 CELLS; RECEPTORS, FC; SERUM ALBUMIN; STATIC ELECTRICITY; TANDEM MASS SPECTROMETRY;

EID: 84946401075     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.10.019     Document Type: Article

References (50)

1. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
2. Mahmoudi M., Sant S., Wang B., Laurent S., Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 2011, 63:24-46.
3. Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., Richie J.P., Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6315-6320.
4. Gao X., Cui Y., Levenson R.M., Chung L.W.K., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22:969-976.
5. Mahon E., Salvati A., Baldelli Bombelli F., Lynch I., Dawson K.A. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J. Control. Release 2012, 161:164-174.
6. Walczyk D., Bombelli F.B., Monopoli M.P., Lynch I., Dawson K.A. What the cell "Sees" in bionanoscience. J. Am. Chem. Soc. 2010, 132:5761-5768.
7. Mahmoudi M., Lynch I., Ejtehadi M.R., Monopoli M.P., Bombelli F.B., Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 2011, 111:5610-5637.
8. Nagayama S., Ogawara K.-i., Fukuoka Y., Higaki K., Kimura T. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int. J. Pharm. 2007, 342:215-221.
9. Furumoto K., Ogawara K.-i., Nagayama S., Takakura Y., Hashida M., Higaki K., Kimura T. Important role of serum proteins associated on the surface of particles in their hepatic disposition. J. Control. Release 2002, 83:89-96.
10. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009, 61:428-437.
11. Lesniak A., Fenaroli F., Monopoli M.P., Åberg C., Dawson K.A., Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012, 6:5845-5857.
12. Zhu Y., Li W., Li Q., Li Y., Li Y., Zhang X., Huang Q. Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles. Carbon 2009, 47:1351-1358.
13. Zhu Z.-J., Posati T., Moyano D.F., Tang R., Yan B., Vachet R.W., Rotello V.M. The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. Small 2012, 8:2659-2663.
14. Lesniak A., Salvati A., Santos-Martinez M.J., Radomski M.W., Dawson K.A., Åberg C. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J. Am. Chem. Soc. 2013, 135:1438-1444.
15. Fleischer C.C., Payne C.K. Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles. J. Phys. Chem. B 2014, 118:14017-14026.
16. Qiu Y., Liu Y., Wang L., Xu L., Bai R., Ji Y., Wu X., Zhao Y., Li Y., Chen C. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31:7606-7619.
17. Cifuentes-Rius A., de Puig H., Kah J.C.Y., Borros S., Hamad-Schifferli K. Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release. ACS Nano 2013, 7:10066-10074.
18. Mirshafiee V., Mahmoudi M., Lou K., Cheng J., Kraft M.L. Protein corona significantly reduces active targeting yield. Chem. Commun. 2013, 49:2557-2559.
19. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., Kelly P.M., Åberg C., Mahon E., Dawson K.A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8:137-143.
20. Sobczynski D.J., Charoenphol P., Heslinga M.J., Onyskiw P.J., Namdee K., Thompson A.J., Eniola-Adefeso O. Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner. PLoS One 2014, 9:e107408.
21. Gref R., Lück M., Quellec P., Marchand M., Dellacherie E., Harnisch S., Blunk T., Müller R.H. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B. Biointerfaces 2000, 18:301-313.
22. Pozzi D., Colapicchioni V., Caracciolo G., Piovesana S., Capriotti A.L., Palchetti S., De Grossi S., Riccioli A., Amenitsch H., Lagana A. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale 2014, 6:2782-2792.
23. Caracciolo G. Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. Nanomed. Nanotechnol. Biol. Med. 2015, 11:543-557.
24. Kreuter J., Shamenkov D., Petrov V., Ramge P., Cychutek K., Koch-Brandt C., Alyautdin R. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 2002, 10:317-325.
25. Zhang Z., Wang C., Zha Y., Hu W., Gao Z., Zang Y., Chen J., Zhang J., Dong L. Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy. ACS Nano 2015, 9:2405-2419.
26. Caracciolo G., Cardarelli F., Pozzi D., Salomone F., Maccari G., Bardi G., Capriotti A.L., Cavaliere C., Papi M., Laganà A. Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles. ACS Appl. Mater. Interfaces 2013, 5:13171-13179.
27. Steinberg B.E., Grinstein S. Analysis of macrophage phagocytosis: quantitative assays of phagosome formation and maturation using high-throughput fluorescence microscopy. Methods Mol. Biol. 2009, 531:45-56.
28. Sobota A., Strzelecka-Kiliszek A., Gładkowska E., Yoshida K., Mrozińska K., Kwiatkowska K. Binding of IgG-opsonized particles to FcγR Is an active stage of phagocytosis that involves receptor clustering and phosphorylation. J. Immunol. 2005, 175:4450-4457.
29. Takasaki S., Emling F., Leive L. Variants deficient in phagocytosis of latex beads isolated from the murine macrophagelike cell line J774. J. Cell Biol. 1984, 98:2198-2203.
30. Cannon G.J., Swanson J.A. The macrophage capacity for phagocytosis. J. Cell Sci. 1992, 101:907-913.
31. Moyano D.F., Goldsmith M., Solfiell D.J., Landesman-Milo D., Miranda O.R., Peer D., Rotello V.M. Nanoparticle hydrophobicity dictates immune response. J. Am. Chem. Soc. 2012, 134:3965-3967.
32. Brown E.J. Complement receptors and phagocytosis. Curr. Opin. Immunol. 1991, 3:76-82.
33. Cabec V.L., Carréno S., Moisand A., Bordier C., Maridonneau-Parini I. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J. Immunol. 2002, 169:2003-2009.
34. Daëron M. Fc receptor biology. Annu. Rev. Immunol. 1997, 15:203-234.
35. Swanson J.A., Hoppe A.D. The coordination of signaling during Fc receptor-mediated phagocytosis. J. Leukoc. Biol. 2004, 76:1093-1103.
36. Potter E.V., Stollerman G.H. The opsonization of bentonite particles by γ-globulin. J. Immunol. 1961, 87:110-118.
37. Ogawara K.-i., Furumoto K., Nagayama S., Minato K., Higaki K., Kai T., Kimura T. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J. Control. Release 2004, 100:451-455.
38. Furumoto K., Yokoe J.-I., Ogawara K.-i., Amano S., Takaguchi M., Higaki K., Kai T., Kimura T. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int. J. Pharm. 2007, 329:110-116.
39. Ogawara K.-i., Yoshida M., Kubo J.-i., Nishikawa M., Takakura Y., Hashida M., Higaki K., Kimura T. Mechanisms of hepatic disposition of polystyrene microspheres in rats: effects of serum depend on the sizes of microspheres. J. Control. Release 1999, 61:241-250.
40. Wang L., Zhao W., O'Donoghu M.B., Tan W. Fluorescent nanoparticles for multiplexed bacteria monitoring. Bioconjug. Chem. 2007, 18:297-301.
41. Tang L., Fan T.M., Borst L.B., Cheng J. Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. ACS Nano. 2012, 6:3954-3966.
42. Shapero K., Fenaroli F., Lynch I., Cottell D.C., Salvati A., Dawson K.A. Time and space resolved uptake study of silica nanoparticles by human cells. Mol. Biosyst. 2011, 7:371-378.
43. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., Mann M. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell Proteomics 2005, 4:1265-1272.
44. van Kessel K.P.M., Bestebroer J., van Strijp J.A.G. Neutrophil-mediated phagocytosis of Staphylococcus aureus. Front. Immunol. 2014, 5:467.
45. Pacheco P., White D., Sulchek T. Effects of microparticle size and Fc density on macrophage phagocytosis. PLoS One 2013, 8:e60989.
46. Raschke W.C., Baird S., Ralph P., Nakoinz I. Functional macrophage cell lines transformed by abelson leukemia virus. Cell 1978, 15:261-267.
47. Leroux J.-C., De Jaeghere F., Anner B., Doelker E., Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. Life Sci. 1995, 57:695-703.
48. Rytel M.W., Stollerman G.H. The opsonic effect of complement on the phagocytosis of γ-globulin-coated bentonite particles. J. Immunol. 1963, 90:607-611.
49. Deng Z.J., Liang M., Monteiro M., Toth I., Minchin R.F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 2011, 6:39-44.
50. Walkey C.D., Olsen J.B., Song F., Liu R., Guo H., Olsen D.W.H., Cohen Y., Emili A., Chan W.C.W. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 2014, 8:2439-2455.